1. Home
  2. SBR vs PRCT Comparison

SBR vs PRCT Comparison

Compare SBR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sabine Royalty Trust

SBR

Sabine Royalty Trust

HOLD

Current Price

$73.21

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$18.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBR
PRCT
Founded
1982
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SBR
PRCT
Price
$73.21
$18.30
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$35.44
AVG Volume (30 Days)
27.8K
1.5M
Earning Date
05-14-2026
04-29-2026
Dividend Yield
6.41%
N/A
EPS Growth
N/A
1.71
EPS
N/A
N/A
Revenue
N/A
$308,054,000.00
Revenue This Year
N/A
$31.34
Revenue Next Year
N/A
$24.52
P/E Ratio
$12.77
N/A
Revenue Growth
N/A
37.22
52 Week Low
$65.15
$16.67
52 Week High
$84.39
$51.18

Technical Indicators

Market Signals
Indicator
SBR
PRCT
Relative Strength Index (RSI) 46.35 38.11
Support Level $72.39 $16.67
Resistance Level $79.65 $29.27
Average True Range (ATR) 1.26 1.04
MACD -0.01 0.11
Stochastic Oscillator 34.25 30.60

Price Performance

Historical Comparison
SBR
PRCT

About SBR Sabine Royalty Trust

Sabine Royalty Trust formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: